Exploring how help-seeking affects allergic rhinitis and mental health
Impact of Help-Seeking Behaviors on Allergic Rhinitis, Asthma Control, and Mental Health: A Retrospective and Longitudinal Analysis of Allergy Medication Use
This study looks at how getting help for allergies and asthma affects both allergy symptoms and mental health, like anxiety and depression, to see if better treatment can improve overall well-being.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 200000 (estimated) |
| Ages | 4 Years to 100 Years |
| Sex | All |
| Sponsor | QHSLab, Inc. Industry-sponsored |
| Locations | 1 site (West Palm Beach, Florida) |
| Trial ID | NCT06623799 on ClinicalTrials.gov |
What this trial studies
This observational study investigates the impact of help-seeking behaviors on allergic rhinitis, asthma control, and mental health outcomes such as anxiety and depression. It utilizes both retrospective and longitudinal data from patients diagnosed with allergic rhinitis and mental health conditions to assess how seeking treatment influences symptom management and quality of life. The research emphasizes the integration of mental health care into allergy treatment plans, analyzing the effects of various allergy medications on both allergic and mental health symptoms. By using validated assessment tools, the study aims to provide insights into coordinated care approaches that can enhance patient outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who are actively receiving care for allergic rhinitis and mental health concerns.
Not a fit: Patients with severe mental health disorders unrelated to the conditions of interest, such as schizophrenia or bipolar disorder, may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with allergic rhinitis and mental health conditions, enhancing their overall quality of life.
How similar studies have performed: While the integration of mental health into allergy treatment is a growing area of interest, this specific approach has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: Adults (aged 18 years or older) Patients actively receiving care in a primary care setting. Patients who have provided informed consent for their health data to be included in the research repository. Exclusion Criteria: Patients who have not provided informed consent for their health data to be included in the research repository. Patients diagnosed with chronic conditions outside the scope of allergic rhinitis, asthma, or mental health conditions (anxiety, depression). Patients with severe mental health disorders or comorbidities that are unrelated to the conditions of interest (e.g., schizophrenia, bipolar disorder, etc.).
Where this trial is running
West Palm Beach, Florida
- QHSLab — West Palm Beach, Florida, United States (Recruiting)
Study contacts
- Study coordinator: Marcos A Sanchez-Gonzalez, MD, PhD
- Email: masanchez@qhslab.com
- Phone: 850-559-7676
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.